Galen Partners is a leading healthcare venture capital firm based in Stamford, Connecticut. The firm focuses on equity investments in healthcare information technology/outsourcing, medical devices and specialty pharmaceutical companies. With nearly $1 billion under management raised through five funds, Galen has invested in more than 70 companies since 1990.
The partnership seeks opportunities to actively participate as a lead investor in which it can provide between $10 million to $30 million of equity capital in healthcare related companies with established revenue.
The firm continues a tradition of strategic collaboration and partnership with its portfolio company management teams. Galen’s capital and guidance has helped to build many healthcare market leaders including Dow Pharmaceutical Sciences (Valeant), EduNeering (Kaplan), Encore Medical (DJO), Lumenos (Wellpoint), MedAssets (MDAS), Medicode (United Healthcare), MiniMed (Medtronic), Ocular Sciences (CooperVision) and Pyxis (Cardinal Health).
Company Details
Galen Partners Questions
Galen Partners's helpline number is 203-653-6400
Galen Partners's website is galen.com
Galen Partners's LinkedIn profile is https://www.linkedin.com/company/galen-partners
Galen Partners has
16 employees.
View email and phone details for 16
employees at Galen Partners.
Galen Partners's industry is
Venture Capital and Private Equity Principals
Galen Partners's top competitors are
Goldman Sachs,
Amulet Capital Partners, Lp,
Affinity Partners,
Healthspot,
Butterfly Network, Inc.,
Vista Ai,
Sovato,
Koan Health,
Oak Investment Partners,
Wynnchurch Capital, L.p..
Galen Partners's categories are Venture Capital and Private Equity Principals
Galen Partners's founding year is 1990
